[Local dissolving of residual and/or recurrent choledochal calculi. Criteria for selecting the patient].
D001646:Bile / Q000032:analysis; D001649:Bile Duct Diseases / Q000188:drug therapy; D001663:Bilirubin / Q000032:analysis; D002210:Caprylates; D002769:Cholelithiasis / Q000188:drug therapy*; D002784:Cholesterol / Q000032:analysis; D019826:Cholic Acid; D002793:Cholic Acids / Q000627:therapeutic use; D005989:Glycerides / Q000627:therapeutic use; D006801:Humans; D012008:Recurrence
D002210:Caprylates; D002793:Cholic Acids; D005989:Glycerides; D002784:Cholesterol; D019826:Cholic Acid; D001663:Bilirubin; C025343:monooctanoin
Dissoluzione locale dei calcoli coledocici residui e/o recidivi. Criteri per selezionare il paziente.